Journals

  1. V. Raparelli, C.M. Norris, U. Bender, M.T. Herrero, A. Kautzky –Willer, K. Kublickiene, K. El Emam, L. Pilote and the GOING‑FWD Collaborators: “Identification and inclusion of gender factors in retrospective cohort studies:the GOING-FWD framework”, BMJ Global Health, 6:e005413, 2021.
  2. Z. Azizi, T. Gisinger, U. Bender, C. Deischinger, V. Raparelli, C.M. Norris, RN, K. Kublickiene, M.T. Herreror, K. El Emam, A. Kautzky-Willer, L. Pilote, and the GOING-FWD Investigators: “Sex, Gender Factors and Cardiovascular Health in Canadian and Austrian populations”, Canadian Journal of Cardiology (accepted), 2021.
  3. Z. Azizi, M. Zheng, L. Mosquera, L. Pilote, K. El Emam: “Replicating Secondary Studies Using Synthetic Clinical Trial Data”, BMJ Open (accepted), 2021.
  4. K. El Emam, L. Mosquera, E. Jonker, H. Sood: “Evaluating the Utility of Synthetic COVID-19 Case Data”, JAMIA Open, 14(1):ooab012, January 2021.
  5. El Emam, L. Mosquera, C. Zheng: “Optimizing the Synthesis of Clinical Trial Data Using Sequential Trees”, Journal of the American Medical Informatics Association 28(1): 3-13, 2021.
  6. K. El Emam, L. Mosquera, J. Bass: “Evaluating Identity Disclosure Risk in Fully Synthetic Health Data”, Journal of Medical Internet Research, 22(11), 2020.
  7. W. Parker, J.L. Jaremko, M. Cicero, M. Azar, K. El Emam, B.G. Gray, C. Hurrell, F. Lavoie-Cardinal, B. Desjardins, A. Lum, L. Sheremeta, E. Lee, C. Reinhold, A. Tang, R. Bromwich: “Canadian Association of Radiologists White Paper on De-Identification of Medical Imaging: Part 1, General Principles”, Canadian Association of Radiologists Journal,  72(1):13-24, 2021.
  8. W. Parker, J.L. Jaremko, M. Cicero, M. Azar, K. El Emam, B.G. Gray, C. Hurrell, F. Lavoie-Cardinal, B. Desjardins, A. Lum, L. Sheremeta, E. Lee, C. Reinhold, A. Tang, R. Bromwich: “Canadian Association of Radiologists White Paper on De-Identification of Medical Imaging: Part 2, Practical Considerations”, Canadian Association of Radiologists Journal, 72(1):25-34, 2021.
  9. El Emam: “Implementing Privacy Enhancing Technologies in the time of a Pandemic”, Journal of Data Protection and Privacy, 3(3), Summer 2020.
  10. K. El Emam, M. Hintze, R. Boardman: “Does de-identification require consent under the GDPR and English Common Law?” Journal of Data Protection and Privacy, 3(3), Summer 2020.
  11. K. El Emam: “Seven Ways to Evaluate the Utility of Synthetic Data”, In IEEE Security and Privacy, 18(4): 56-59, July-Aug, 2020.
  12. J. Branson, N. Good, J. Chen, W. Monge, C. Probst, K. El Emam. “Evaluating the re-identification risk of a clinical study report anonymized under EMA Policy 0070 and Health Canada Regulations”. In Trials 21:200, 2020.
  13. K. El Emam: “Expanding the role of PETs in the data protection and privacy narrative”, In Journal of Data Protection and Privacy, 2(3):198-200, 2019.
  14. M. Hintze and K. El Emam: “Comparing the benefits of pseudonymisation and anonymisation under the GDPR”, In Journal of Data Protection and Privacy, 2(2):145-158, 2018.
  15. Anthony L. VaccarinoMoyez Dharsee, Stephen Strother, Don Aldridge, Stephen R. Arnott, Brendan BehanCostas Dafnas, Fan Dong, Kenneth EdgecombeRachad El-BadrawiKhaled El-Emam, Tom Gee, Susan G. Evans, Mojib Javadi, Francis Jeanson, Shannon Lefaivre, Kristen Lutz, F. Chris MacPhee, Jordan Mikkelsen, Tom Mikkelsen, Nicholas Mirotchnick, Tanya Schmah, Christa M. Studzinski, Donald T. Stuss, Elizabeth Theriault and Kenneth R. Evans:  “Brain-CODE: A Secure Neuroinformatics Platform for Management, Federation, Sharing and Analysis of Multi-Dimensional Neuroscience Data, In Frontiers in Neuroinformatics, May, 2018.
  16. N. Persaud, C. Meaney, K. El Emam, R. Moineddin, K. Thorpe: “Doxylamine-pyridoxine for nausea and vomiting of pregnancy randomized placebo controlled trial: prespecified analyses and reanalysis“. PLOS ONE, 13(1): e0189978, January 2018.
  17. G.M. Jacquez, A. Essex, A. Curtis, B. Kohler, R. Sherman, K. El Emam, C. Shi, A. Kaufmann, L. Beale, T. Cusick, D. Goldberg, P. Goovaerts: “Geospatial cryptography: Enabling researchers to access private, spatially referenced, human subjects data for cancer control and prevention“. In Journal of Geographic Systems, 19(3):197-220, July 2017.
  18. L. Arbuckle, E. Moher. S. Ahmed, S. Bartlett, K. El Emam: “Montreal Accord on Patient-Reported Outcomes Use Series – Paper 9: Anonymization and Ethics Considerations for Capturing and Sharing Patient Reported Outcomes”. In Journal of Clinical Epidemiology, 89:168-172, September 2017.
  19. K. El Emam: “An Overview of Anonymization Practices in Initial Data Releases Pursuant to EMA Policy 0070”. In Applied Clinical Trials, April 13, 2017.
  20. M. Scaiano, G. Middleton, L. Arbuckle, V. Kolhatkar, L. Peyton, M. Dowling, D.S. Gipson, K. El Emam: “A unified framework for evaluating the risk of re-identification of text de-identification tools”. In Journal of Biomedical Informatics, 63:174-183, 2016.
  21. K. El Emam: “Medical Data Privacy Handbook, A. Gkoulalas-Divanis, G. Loukides. Springer International Publishing, Switzerland (2015). 832 pp., ISBN: 978-3-319-23633-9″. (Book Review), In Journal of Biomedical Informatics, 62:106, 2016.
  22. E. Moher, K. El Emam: “The Ethical Merits of Nudges in the Clinical Setting“. In American Journal of Bioethics, 15(10):54-5, 2015.
  23. K. El Emam, H. Farah, S. Samet, A. Essex, E. Jonker, M. Kantarcioglu, C. Earle: “A Privacy Preserving Protocol for Tracking Participants in Phase I Clinical Trials”. In Journal of Biomedical Informatics, October 2015, 57:145-162.
  24. K. El Emam, S. Rodgers, B. Malin: “Anonymizing and Sharing Individual Patient Level Data.” In BMJ 350:h1139, 2015.
  25. K. El Emam, K. Abdallah: “De-identifying Clinical Trials Data”. In Applied Clinical Trials, 24(8), 2015.